Nvidia's stock slips. The FDA will evaluate a third round of data on Pfizer's vaccine for children six months and up. And Ford's rough ride. Host: Zoe Szathmary.
Nvidia's stock slips. The FDA will evaluate a third round of data on Pfizer's vaccine for children six months and up. And Ford's rough ride. Host: Zoe Szathmary.